France LASIK Surgery Market was valued at $97.08 Mn in 2023 and is predicted to grow at a CAGR of 4.21% from 2023 to 2030, to $129.56 Mn by 2030. The key drivers of this industry include a high prevalence, strong economy, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
France LASIK Surgery Market was valued at $97.08 Mn in 2023 and is predicted to grow at a CAGR of 4.21% from 2023 to 2030, to $129.56 Mn by 2030.
LASIK, or laser-assisted in situ keratomileusis, is a popular refractive surgery that reshapes the cornea to correct vision problems like near sightedness, farsightedness, and astigmatism, significantly reducing dependence on eyeglasses or contact lenses. Before surgery, an ophthalmologist performs a comprehensive eye exam to determine candidacy. The outpatient procedure, lasting about 15-30 minutes per eye, involves creating a thin corneal flap with a microkeratome or femtosecond laser, reshaping the underlying corneal tissue with an excimer laser, and repositioning the flap without stitches. Post-surgery, patients may experience temporary discomfort and blurred vision, with risks including dry eyes, glare, halos, infection, and rare vision under or overcorrections.
In southern Germany, common eye diseases among older adults include cataracts (36% prevalence), dry eyes (15%), glaucoma (9%), and age-related macular degeneration (AMD). A study estimated the age-standardized incidence of severe binocular vision impairment and blindness (SVI/B) in France to be 79 per 100,000 person-years, with AMD accounting for 50% of SVI/B at 5.56 per 100,000 person-years, followed by glaucoma at 15% or 1.65 per 100,000 person-years. Market is therefore driven by significant factors like high prevalence, growing disposable income, and increasing awareness. However, the high cost of surgery, competition from alternatives, and cultural considerations restrict the growth and potential of the market.
A prominent player in this field is Johnson & Johnson Vision, Zeimer which announced a collaboration with Schwind eye-tech-solutions to develop a new femtosecond laser platform for various ophthalmic applications, including LASIK surgery on June 2023. Other contributors include Abbott, and Carl ZEISS AG among others.
Market Growth Drivers
Rising Prevalence: France faces a significant public health issue with over 30% of adults experiencing myopia, which creates a substantial patient base seeking effective corrective solutions. This high prevalence drives demand for LASIK surgery as a permanent alternative to glasses or contact lenses. As more individuals are diagnosed with vision issues, the need for advanced surgical options like LASIK continues to grow, bolstering the market.
Growing Disposable Income: With the French economy on a steady growth trajectory, many citizens are enjoying increased disposable income, making elective surgeries more financially viable. This rising income level encourages individuals to invest in personal health and appearance, contributing to a growing acceptance of LASIK as a life-enhancing procedure. The shift towards consumerism further fuels interest in aesthetic and health-related investments, expanding the market for LASIK.
Increasing Awareness and Marketing: Effective marketing campaigns by eye care providers and medical facilities have significantly raised awareness about the benefits of LASIK surgery among the French population. Public education initiatives focus on the safety, efficacy, and convenience of LASIK, attracting more potential patients. This increased visibility not only informs the public but also promotes a positive perception of LASIK, further driving demand.
Market Restraints
High Cost of Surgery: Despite the growing interest in LASIK, the procedure can be prohibitively expensive for many French citizens, especially relative to average national income levels. The high costs associated with advanced technologies and skilled surgeons create a significant financial barrier, limiting access to the broader population. This economic hurdle often leads potential patients to forgo surgery in favour of more affordable alternatives.
Limited Public Insurance Coverage: LASIK is primarily viewed as an elective procedure, leading to limited coverage under the French national health insurance system (Sécurité Sociale). Most patients must bear the full cost of surgery out of pocket, which can discourage those with financial constraints from pursuing the procedure. Although exceptional cases may receive coverage, these situations are rare and poorly defined, further complicating access.
Competition from Alternative: The presence of alternative vision correction options, such as contact lenses and spectacles, provides strong competition to LASIK surgery. Many individuals opt for these less invasive and often more affordable solutions, which can deter them from considering surgical options. This competition is particularly significant among those who prioritize lower initial costs or prefer non-surgical interventions.
France has a comprehensive regulatory framework for LASIK surgery, overseen by several key bodies. The Ministry of Health defines the legal framework for medical procedures, including LASIK. The National Agency for the Safety of Medicines and Health Products (ANSM) regulates medical devices used in LASIK, ensuring they meet safety and efficacy standards. The National Council of the Order of Physicians (CNOM) sets ethical guidelines for medical practice, including ophthalmology. Key regulations for LASIK in France include strict pre-operative assessments, use of ANSM-approved devices, mandatory informed consent procedures, and standardized post-operative care protocols.
LASIK surgery in France is generally an elective procedure with limited reimbursement options. The French National Health Insurance (Sécurité Sociale) typically does not cover LASIK unless severe medical circumstances exist. Some private health insurance plans may offer partial coverage, but patients usually need to pay out-of-pocket. Costs can vary based on the surgeon's experience, technology used, and the facility, with some clinics offering financing options to help manage expenses.
Key Players
Here are some of the major key players in the France LASIK Surgery
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type
By Vision Error
By Product
By End-User
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.